Recent Advances in Diagnostics and Therapeutics for Cytomegalovirus Management: Recent Advances in Kidney Transplantation (KSN 2025) - Jun 19, 2025 - Abstract #KT01-S4; Pres time: Jun 20, 2025; 04:00 PM - 04:30 PM; Location: Room 2(GBR 102); "Therapeutically, the emergence of newer agents such as letermovir and maribavir has expanded the available options for both prophylaxis and treatment. Collectively, these innovations reflect a shift toward precision medicine in CMV management. Continued research into viral-host interactions, immunologic monitoring, and optimized combination therapies will be essential to improving outcomes and reducing the disease burden in susceptible patient populations."
IO biomarker • Bone Marrow Transplantation • Cytomegalovirus Infection • Transplant Rejection • Transplantation
|